Chinese medicament capsule for treating tracheitis

Abstract

The invention provides a Chinese medicament capsule for treating tracheitis. The Chinese medicament capsule is prepared by repeatedly testing and verifying in clinical tests, and accords with a theory of the traditional Chinese medicine. The Chinese medicament capsule is prepared from the following Chinese medicament raw materials: gleditsia seed, ephedra, white flower hogfennel root, radish seed, largehead atractylodes rhizome, indian buead, plaster, perilla leaf, tatarian aster root, ginkgo seed, lance asiabell root, white mulberry root-bark, forsythia, baikal skullcap root, common anemarrhena rhizome, Chinese waxgourd semen, reed rhizome, pepperweed seed, bitter orange, white mustard seed, Chinese atractylodes rhizome, officinal magnolia bark, heartleaf houttuynia herb and blackberrykiky rhizome. The Chinese medicament capsule uses Chinese traditional medicinal herbs as raw materials, and is prepared according to a scientific formula, so that the Chinese medicament capsule has the effects of relieving cough, relieving asthma, descending qi to reduce phlegm, moistening the lung to tonify deficiency, and improving immunity. The Chinese medicament capsule for treating the tracheitis has the following advantages that: the effect can be obtained quickly, the course of treatment is short, the range is wide, and Chinese medicament capsule can consolidate the constitution and prevent relapse; a large number of patients get desired results after taking the capsule for one week; and the Chinese medicament capsule has a strong curative effect of treating various symptoms such as asthma, short breath, more phlegm and the like of lung.

Description

technical field [0001] The invention relates to a traditional Chinese medicine capsule, in particular to a traditional Chinese medicine capsule for treating tracheitis. Background technique [0002] Tracheitis is a common respiratory disease and one of the world's four major chronic diseases. It has a high incidence and rapid onset. At present, there are about 300 million people in the world suffering from this disease, and there are 30 million patients in my country. The prevalence is about 0.5%-1.5%, and it is gradually increasing every year. More slow onset, longer course, repeated acute attacks and increased the weight of. The main symptoms are chronic cough, expectoration, and wheezing. Symptoms are mild at the beginning, such as smoking, exposure to harmful gases, overwork, climate change or cold cold, causing acute attack or aggravation. Or the upper respiratory tract infection persists and develops into chronic bronchitis, which can be relieved naturally when the ...

AI Technical Summary

Problems solved by technology

It can be seen that untimely and improper treatment of bronchitis may cause life-threatening

At present, there are many drugs for the treatment of bronchitis, which are generally antibacterial and anti-inflammatory and relax the tracheal smooth muscle. Long-term use will cause side effects and increase the heart rate. Although there are also Chinese patent drugs, the effect is not significant

Images